TAIHO PHARMA

Otsuka group of companies 100th Anniversary
Exploring hidden
possibilities for
people awaiting
new medicines

We mourn the loss of those who have died from COVID-19, extend our sympathies to their loved ones, wish COVID-19 survivors rapid and permanent recoveries, and express our gratitude to medical professionals and others who support the ill.

About Taiho

Becoming a truly global specialty pharma that meets the expectations of patients worldwide.

Our Business

Taiho Pharmaceutical creates innovative, highly valuable new drugs to support patients and the advancement of medicine, seeking to contribute to smiles and health for people all around the world.

News Releases

September 14, 2021

Taiho Pharmaceutical Submits New Drug Application for its HSP90 Inhibitor Pimitespib (TAS-116) for GIST
September 06, 2021

"Efil" Virus Removal/Antibacterial Spray Marks Its Debut Outside Japan, to Support Peace of Mind in Daily Life for People in Singapore "Turn your life around with Efil"
September 06, 2021

Taiho Pharmaceutical Relocates Head Office
September 01, 2021

Taiho Pharmaceutical's Drug Discovery Site in Tsukuba Fully Switches to Carbon-Neutral Electricity, and Newly Adopts Carbon Neutral City Gas
Annual CO₂ Emissions of the Tsukuba Area to Decline by Approximately 56% （PDF：100.8 KB）
September 01, 2021

100th Anniversary of Otsuka Group of Companies Looking Ahead to the Next 100 Years

Information

August 06, 2021

Otsuka Holdings announces 2Q FY2021 financial results
July 12, 2018

Announcement of Support from Otsuka Holdings and Its Group Companies in the Aftermath of Severe Storms in Japan（PDF：165.9 KB）